- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x ZN: ZINC ION(Non-covalent)
- 1 x HJ5: [(1~{R})-1-[[(2~{S})-2-[[(2~{S})-1-azaniumyl-1-oxidanylidene-3-phenyl-propan-2-yl]carbamoyl]pent-4-ynyl]-oxidanyl-phosphoryl]-3-phenyl-propyl]azanium(Non-covalent)
- 1 x B3P: 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)
B3P.7: 15 residues within 4Å:- Chain A: F.405, D.406, E.409, K.526, N.616, S.623, Q.650, N.653, E.654, P.657, M.658, L.661, E.892, N.893, W.896
17 PLIP interactions:17 interactions with chain A- Hydrogen bonds: A:D.406, A:K.526, A:N.616, A:S.623, A:Q.650, A:P.657, A:E.892, A:E.892
- Water bridges: A:G.402, A:F.405, A:E.409, A:E.409, A:K.526, A:N.616, A:S.623, A:Q.650, A:N.653
- 30 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.8: 11 residues within 4Å:- Chain A: H.98, E.129, H.160, T.185, A.186, R.188, M.189, P.426, R.430, E.840
- Ligands: EDO.12
Ligand excluded by PLIPEDO.9: 8 residues within 4Å:- Chain A: S.340, A.341, S.342, R.700, M.701, S.704, D.741
- Ligands: EDO.26
Ligand excluded by PLIPEDO.10: 4 residues within 4Å:- Chain A: D.550, M.551, V.552
- Ligands: P6G.39
Ligand excluded by PLIPEDO.11: 6 residues within 4Å:- Chain A: F.555, V.563, L.564, I.565
- Ligands: EDO.25, P6G.39
Ligand excluded by PLIPEDO.12: 9 residues within 4Å:- Chain A: I.52, R.127, Q.128, E.129, R.188, N.425, P.426
- Ligands: EDO.8, EDO.17
Ligand excluded by PLIPEDO.13: 9 residues within 4Å:- Chain A: F.76, N.154, L.155, S.156, H.160, G.161, F.162, M.189, A.190
Ligand excluded by PLIPEDO.14: 8 residues within 4Å:- Chain A: A.427, L.841, K.874, E.875, G.877, S.878, Q.879, L.880
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain A: N.370, D.371, S.420, T.421, P.422, L.501
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain A: F.544, S.549, H.553, L.566, P.567
- Ligands: P6G.39
Ligand excluded by PLIPEDO.17: 12 residues within 4Å:- Chain A: I.52, H.96, T.185, R.188, D.195, E.196, W.368, E.424, N.425, P.426, I.429
- Ligands: EDO.12
Ligand excluded by PLIPEDO.18: 6 residues within 4Å:- Chain A: T.643, E.644, I.645, S.698, E.699, L.702
Ligand excluded by PLIPEDO.19: 9 residues within 4Å:- Chain A: H.417, T.421, P.422, V.423, Q.428, E.431, M.432, R.881
- Ligands: EDO.36
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain A: R.515, P.567, E.568, E.569
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain A: W.691, R.721, Y.725
Ligand excluded by PLIPEDO.22: 9 residues within 4Å:- Chain A: M.662, E.663, K.664, R.665, M.667, N.668, E.671, P.818, Y.821
Ligand excluded by PLIPEDO.23: 7 residues within 4Å:- Chain A: L.66, H.68, W.77, G.78, T.79, H.150, R.208
Ligand excluded by PLIPEDO.24: 2 residues within 4Å:- Chain A: K.548, E.568
Ligand excluded by PLIPEDO.25: 3 residues within 4Å:- Chain A: I.565
- Ligands: EDO.11, P6G.39
Ligand excluded by PLIPEDO.26: 8 residues within 4Å:- Chain A: S.340, S.342, S.704, V.740, L.744, T.771, Q.775
- Ligands: EDO.9
Ligand excluded by PLIPEDO.27: 7 residues within 4Å:- Chain A: F.433, D.434, D.435, Y.438, S.844, H.848
- Ligands: HJ5.6
Ligand excluded by PLIPEDO.28: 5 residues within 4Å:- Chain A: R.829, K.830, W.832, N.833, F.869
Ligand excluded by PLIPEDO.29: 4 residues within 4Å:- Chain A: A.198, E.367, K.471, N.472
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain A: R.665, M.667, M.897, D.898, F.901
Ligand excluded by PLIPEDO.31: 5 residues within 4Å:- Chain A: Q.315, S.316, G.317, R.328
- Ligands: HJ5.6
Ligand excluded by PLIPEDO.32: 5 residues within 4Å:- Chain A: F.649, L.652, N.653, I.656, Q.705
Ligand excluded by PLIPEDO.33: 7 residues within 4Å:- Chain A: H.68, A.69, N.70, T.75, F.76, W.77
- Ligands: NAG-NAG-BMA.2
Ligand excluded by PLIPEDO.34: 4 residues within 4Å:- Chain A: P.48, W.49, N.50, K.51
Ligand excluded by PLIPEDO.35: 8 residues within 4Å:- Chain A: K.338, W.729, L.736, S.737, L.738, T.743, F.747, E.772
Ligand excluded by PLIPEDO.36: 6 residues within 4Å:- Chain A: S.416, H.417, P.418, T.421, R.881
- Ligands: EDO.19
Ligand excluded by PLIPEDO.37: 4 residues within 4Å:- Chain A: N.497, T.498, L.501, Q.502
Ligand excluded by PLIP- 1 x MLT: D-MALATE(Non-covalent)
- 1 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 3 x NA: SODIUM ION(Non-functional Binders)
NA.41: 5 residues within 4Å:- Chain A: Q.315, S.843, S.844, S.845
- Ligands: HJ5.6
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Q.315, A:S.844, A:S.845
NA.42: 5 residues within 4Å:- Chain A: Q.181, F.314, Q.315, S.316
- Ligands: HJ5.6
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Q.315, A:S.316, A:S.316
NA.43: 4 residues within 4Å:- Chain A: E.431, L.880, R.881, C.882
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:E.431, A:R.881, A:C.882
- Water bridges: A:G.842
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Giastas, P. et al., High-Resolution Crystal Structure of Endoplasmic Reticulum Aminopeptidase 1 with Bound Phosphinic Transition-State Analogue Inhibitor. Acs Med.Chem.Lett. (2019)
- Release Date
- 2019-04-10
- Peptides
- Endoplasmic reticulum aminopeptidase 1,Endoplasmic reticulum aminopeptidase 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.60 Å
- Oligo State
- monomer
- Ligands
- 1 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x ZN: ZINC ION(Non-covalent)
- 1 x HJ5: [(1~{R})-1-[[(2~{S})-2-[[(2~{S})-1-azaniumyl-1-oxidanylidene-3-phenyl-propan-2-yl]carbamoyl]pent-4-ynyl]-oxidanyl-phosphoryl]-3-phenyl-propyl]azanium(Non-covalent)
- 1 x B3P: 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)
- 30 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 1 x MLT: D-MALATE(Non-covalent)
- 1 x P6G: HEXAETHYLENE GLYCOL(Non-functional Binders)
- 1 x PG4: TETRAETHYLENE GLYCOL(Non-functional Binders)
- 3 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Giastas, P. et al., High-Resolution Crystal Structure of Endoplasmic Reticulum Aminopeptidase 1 with Bound Phosphinic Transition-State Analogue Inhibitor. Acs Med.Chem.Lett. (2019)
- Release Date
- 2019-04-10
- Peptides
- Endoplasmic reticulum aminopeptidase 1,Endoplasmic reticulum aminopeptidase 1: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A